Paige.Ai

Paige.Ai

Platform or rapid diagnostic

Company website
Foundation year

2017

Pre-IPO

Current offer

Placement price Available after authorization
Minimum investment Available after authorization
Available volume Available after authorization
Make a request

About

Developer of a computational pathology module platform aimed at swift diagnostic stratification and cancer detection. The platform utilizes deep learning algorithms based on convolutional and recurrent neural networks, as well as generative models, focusing on breast, prostate, and other major cancer types. This allows clinical researchers and pathologists to understand disease progression with various mutations for more effective treatment.

Investors

Healthcare Venture Partners,    
Palkon Capital Management,
Casdin Capital     Venture Capital,
Catalio Capital Management,    
Johnson & Johnson Innovation


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.